(Q28564620)

31 January 2017

title

Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase (English)

1 reference

31 January 2017

0 references

1 reference

1 reference

Yongzhong Wei

1

1 reference

31 January 2017

James R. Sowers

2

1 reference

31 January 2017

Suzanne E. Clark

3

1 reference

31 January 2017

Wenhan Li

4

1 reference

31 January 2017

Carlos M. Ferrario

5

1 reference

31 January 2017

Craig S. Stump

6

1 reference

31 January 2017

publication date

1 February 2008

1 reference

American Journal of Physiology - Endocrinology and Metabolism

31 January 2017

published in

1 reference

31 January 2017

volume

294

1 reference

31 January 2017

issue

2

1 reference

31 January 2017

page(s)

E345–351

1 reference

Series introduction: the transcription factor NF-kappaB and human disease

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

TNF-alpha and insulin resistance: summary and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Angiotensin II induces insulin resistance independent of changes in interstitial insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Hypertension, angiotensin II, and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Effect of antihypertensive agents on the development of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

The metabolic syndrome: role of skeletal muscle metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00456.2007

10.1152/AJPENDO.00456.2007

21 January 2018

Identifiers

DOI

1 reference

31 January 2017

1 reference